Source: https://www.arthritisresearch.us/contact-dermatitis/references-whd.html
Timestamp: 2019-04-19 22:40:32+00:00

Document:
1. Hadgraft J, Guy R, eds. Transdermal Drug Delivery. New York: Marcel Dekker, 1989.
2. Guy R. Current status and future prospects for transdermal drug delivery. Pharm Res 1996; 13:1765-1769.
3. Walters K, Hadgraft J, eds. Pharmaceutical Skin Permeation Enhancement. New York: Marcel Dekker, 1993.
4. Barry B, Williams A. Permeation enhancement through skin. In: Swarbick J, Boylan J, eds. Encyclopedia of Pharmaceutical Technology, Vol. 11. 1995:449-493.
5. Sage B. Iontophoresis. In: Swarbick J, Boylan J, eds. Encyclopedia of Pharmaceutical Technology, Vol. 8. 1993:217-247.
6. Singh P, Maibach H. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Therap Drug Carrier Syst 1994; 11:161-213.
7. Singh P, Maibach H. Iontophoresis: an alternative to the use of carriers in cutaneous drug delivery. Adv Drug Del Rev 1996; 18:379-394.
8. Roberts M, Lai M, Cross S, Yoshida N. Solute transport as a determinant of iontophoretic transport. In: Potts R, Guy R, eds. Mechanisms of Transdermal Drug Delivery. New York: Marcel Dekker, 1997:291-349.
9. Banga A. Clinical applications of iontophoresis devices for topical dermatological delivery. In: Banga A, ed. Electrically Enhanced Transdermal Drug Delivery. Francis & Taylor, 1998: 57-74.
10. Gargarosa L, Ozawa A, Ohkido M, Shimomura Y, Hill J. Iontophoresis for enhancing penetration of dermatologic and antiviral drugs. J Dermatol 1995; 22:865-875.
11. Gargarosa L, Hill M. Modern iontophoresis for local drug delivery. Int J Pharm 1995; 123: 159-171.
12. Singh J, Bhatia K. Topical iontophoretic drug delivery: pathways, principles, factors and skin irritation. Med Res Rev 1996; 16:285-296.
13. Costello C, Jeshe A. Iontophoresis: applications in transdermal medication delivery. Phys Ther 1995; 75:554-563.
14. Green P. Iontophoretic delivery of peptides drug. J Control Release 1996; 41:33-48.
15. Phipps JB, Gyory J. Transdermal ion migration. Adv Drug Del Rev 1992; 9:137-176.
16. Pikal M. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Del Rev 1992; 9:201-237.
17. Hirvonen Y, Guy R. Transdermal iontophoresis: modulation of electroosmosis by polypep-tides. J Control Release 1998; 50:283-289.
18. Rao G, Guy R, Glikfeld P, LaCourse W, Leung L, Tamada J, Potts R, Azimi N. Reverse iontophoresis: non invasive glucose monitoring in vivo in humans. Pharm Res 1995; 12:18691873.
19. Cullander C. What are the pathways of iontophoretic current flow through mammalian skin? Adv Drug Del Rev 1992; 9:119-135.
20. Scott E, Laplazza A, White H, Phipps B. Transport of ionic species in skin: contribution of pores to the overall skin conductance. Pharm Res 1993; 10:1699-1709.
21. Monteiro-Riviere N. Identification of the pathways of transdermal iontophoretic drug delivery: light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 1994; 11:251256.
22. Turner N, Ferry L, Price M, Cullander C, Guy R. Iontophoresis of poly-L-lysines: the role of molecular weight? Pharm Res 1997; 14:1322-1331.
23. Regnier V, Preat V. Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm Res 1998; 15: 1596-1602.
24. Preat V, Vanbever R, Jadoul A, Regnier V. Electrically enhanced transdermal drug delivery: iontophoresis vs electroporation. In: Couvreur P, Duchene D, Green P, Junginger H, eds. Transdermal administration, a case study, Iontophoresis. Paris: Editions de la sante. 1997:5867.
25. Jadoul A, Mesens J, de Beukelaer F, Crabbe R, Preat V. Transdermal permeation of alnitidan by iontophoresis: in vitro optimization and human pharmacokinetic data. Pharm Res 1996; 13:1347-1352.
26. Jadoul A, Bouwstra J, Preat V. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Del Rev 1999; 35:89-106.
27. Kalia Y, Nomato LD, Guy R. The effect of iontophoresis on skin barrier integrity: non invasive investigation by impedance spectroscopy and transepidermal water loss. Pharm Res 1996; 13: 957-961.
28. Thysman S, Van Neste D, Preat V. Non invasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol 1995; 8:229-236.
29. Jadoul A, Doucet J, Durand D, Preat V. Modifications induced on stratum corneum by iontophoresis: ATR-FTIR and x-ray scattering studies. J Control Release 1996; 42:165-173.
30. Craane-vanHinsberg W, Verhoef J, Spies F, Bouwstra J, Gooris G, Junginger H, Bodde H. Electroperturbation on the human skin barrier in vitro (II) effects on the stratum corneum lipid ordering and ultrastructure. Micros Res Tech 1997; 37:200-213.
31. Ledger P. Skin biological in electrically enhanced transdermal delivery. Adv Drug Del Rev 1992; 9:289-307.
32. Prausnitz M. The effects of electric current applied to skin: a review for transdermal drug delivery. Adv Drug Del Rev 1996; 18:395 -425.
33. Fouchard D, Hueber F, Teillaud E, Marty JP. Effect of iontophoretic current flow on hairless rat skin in vivo. J Control Release 1997; 49:89-99.
34. Vandergeest R, Elshove D, Danhof M, Lavrijsen A, Bodde H. Non-invasive assessment of skin barrier integrity and skin irritation following iontophoretic current application in humans. J Control Release 1996; 41:205-213.
35. Vanbever R, Fouchard D, Jadoul A, De Morre N, Preat V, Marty J-P. In vivo non-invasive evaluation of hairless rat skin after high-voltage pulse exposure. Skin Pharmacol Appl Skin Physiol 1998; 11:23 -34.
36. Park N, Gangorasa C, Hill J. Iontophoretic application of Ara-AMP (9b-D-arabinofuranoyl-adenine-5-monophosphate) into adult mouse skin. Proc Soc Exp Biol Med 1977; 156:326329.
37. Singh P, Roberts M. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J Pharm Sci 1993; 82:127-131.
38. Jadoul A, Hanchard C, Thysman S, Preat V. Quantification and localization of fentanyl and TRH delivered by iontophoresis in the skin. Int J Pharm 1995; 120:221-228.
39. Volpato N, Nicoli S, Laureri C, Colombo P, Santi P. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release 1998; 50:291-296.
40. Hill A, Baker G, Jansen G. Mechanism of action of iontophoresis in the treatment of palmar hyperhidrosis. Cutis 1981; 28:69-72.
41. Holzle E, Alberti N. Long-term efficacy and side effects of tap water iontophoresis of pal-moplantar hyperhidrosis. The usefulness of home therapy. Dermatologica 1987; 175:126.
42. Lener EV, Bucalo B, Kist D, Moy R. Topical anesthetic agents in dermatologic surgery: a review. Dermatologic Surg 1997; 23:673-683.
43. Ashburn M, Gauthier M, Love G, Basta S, Gaylord B, Kessler K. Iontophoretic administration of 2% lidocaine HCl and 1: 100,000 epinephrine in humans. Clin J Pain 1997; 13:22-26.
44. Zempsky W, Arand K, Sullivan K, Fraser D, Wana K. Lidocaine iontophoresis for topical anesthesia before intravenous line placement in children. J Pediatr 1998; 132:1061-1063.
45. Greenbaum SS, Bernstein EF. Comparison of iontophoresis of lidocaine with a eutectic mixture of lidocaine and prilocaine (EMLA) for topically administered local-anesthesia. J Derma-tolog Surg Oncology 1994; 20:579-583.
46. Irsfeld S, Klement W, Lipfert P. Dermal anaesthesia: comparison of EMLA cream with iontophoretic local anaesthesia. Br J Anaesth 1993; 71:375.
47. Hasson S, Daniels J, Schieb D. Exercise training and dexamethasone iontophoresis in rheumatoid arthritis. Physiotherapy Canada 1991; 43:11-14.
48. Bertolucci L. Introduction of antiinflammatory drugs by iontophoresis: double blind study. J Orthop Sports Phys Ther 1982; 4:103-108.
49. Gibson L, Cooke R. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959; 23:545.
50. Gordon A, Weinstein M. Sodium salicylate iontophoresis in the treatment of plantar warts. Phys Ther 1968; 49:869.
51. Kahn J. Acetic acid iontophoresis for calcium deposit. Phys Ther 1977; 57:658.
52. Asai J, Fukuta K, Torii S. Topical administration of prostaglandin Ej with iontophoresis for skin flap viability. Ann Plast Surg 1997; 38:514-517.
53. Saeki S, Yamamura K, Matsushita M, Niishikimi N, Sakurai T, Nimura Y. Iontophoretic application of prostaglandin E1 for improvement in peripheral microcirculation. Int J Clin Pharmac Ther 1998; 36:525-529.
54. Schmidt JB, Binder M, Macheines UV, Bieglmager C. New treatment of atrophic acne scars by iontophoresis with estriol and tretinoin. Int J Dermatol 1995; 34:53-57.
55. Tannenbaum M. Iodine iontophoresis in reducing scar tissue. Phys Ther 1980; 60:792.
56. Shigeni S, Murakami T, Yata N, Ikuta Y. Treatment of keloid and hypertrophic scars by iontophoretic transdermal delivery of tranilast. Scand J Plast Reconstr Surg Hand Surg 1997; 31:151-158.
57. Zhao L, Hung L, Choy T. Delivery of medication by iontophoresis to treat post-burn hypertrophic scars: investigation of a new electronic technique. Burns 1997; 23(suppl 1):S27-S29.
58. Rhodes L, Tsoukas M, Anderson R, Kollias N. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997; 108:87-91.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.